GL1X · GenesisL1 explorer

MolNFT v1 · #156715 · protein

Crystal structure of human ppargamma ligand binding domain in complex with rosiglitazone and oleic acid

6MD4 · Peroxisome proliferator-activated receptor gamma: “Crystal structure of human ppargamma ligand binding domain in complex with rosiglitazone and oleic acid”. X-ray diffraction, 2 ligands (BRL, OLA), 7 pockets (best druggability…

PDB
6MD4
Type
protein
Length
509 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Peroxisome proliferator-activated receptor gamma
UniProt
P37231
Ligands
BRL, OLA
Pockets
7 · best druggability 0.81

Structure

x-ray diffraction · 2 distinct chains · 67% helix, 5% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APeroxisome proliferator-activated receptor gammaprotein25867% helix, 5% strandP37231
BPeroxisome proliferator-activated receptor gammaprotein25167% helix, 5% strandP37231

Ligands and binding sites

  • BRL · 2,4-thiazolidiinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-(9CL) · ligand · chains A
  • OLA · Oleic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17290.810.8472empty
24750.790.8650BRL, OLA
33130.580.7725empty
4950.530.8420empty
51710.450.7521empty

Interfaces

1 interface between chains.

  • A–B · 1005 Ų buried · 13 hydrogen bonds · protein-protein

Compared structures

  • 6MD4 · Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Rosiglitazone… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.